Rapid Colorimetric Method for Testing Susceptibility of Mycobacterium tuberculosis to Isoniazid and Rifampin in Liquid Cultures
|
|
- Tyrone Hawkins
- 5 years ago
- Views:
Transcription
1 JOURNAL OF CLINICAL MICROBIOLOGY, Nov. 2003, p Vol. 41, No /03/$ DOI: /JCM Copyright 2003, American Society for Microbiology. All Rights Reserved. Rapid Colorimetric Method for Testing Susceptibility of Mycobacterium tuberculosis to Isoniazid and Rifampin in Liquid Cultures H. Syre, 1 S. Phyu, 1 P. Sandven, 2 B. Bjorvatn, 1 and H. M. S. Grewal 1 * Department of Microbiology and Immunology, The Gade Institute and Haukeland University Hospital, University of Bergen, N-5021 Bergen, 1 and Norwegian Institute of Public Health, Oslo, 2 Norway Received 26 March 2003/Returned for modification 23 May 2003/Accepted 16 July 2003 We have developed a rapid colorimetric method for testing the susceptibility of M. tuberculosis to isoniazid (INH) and rifampin (RIF) based on incorporation of nitrate in broth cultures containing growth supplements. The performance of this colorimetric nitrate reductase-based antibiotic susceptibility (CONRAS) test was compared with that of the radiometric BACTEC 460TB system in determining the susceptibilities of 74 M. tuberculosis strains to INH and RIF. By using the BACTEC 460TB system as the gold standard, the sensitivity (i.e., the ability to detect true drug resistance) and specificity (i.e., the ability to detect true drug susceptibility) of the CONRAS test were 100 and 95% for INH and 94 and 100% for RIF, respectively. The repeatability of the CONRAS test was excellent (for INH, kappa 1 and P < 0.001; for RIF, kappa 0.88 and P < 0.001). For the majority of strains, results were obtained within 5 days. The CONRAS test is rapid, accurate, and inexpensive and is an adequate alternative, particularly for resource-poor countries. The resurgence of tuberculosis (TB) worldwide has been accompanied by an increase in the incidence of drug-resistant TB and, more importantly, also in that of multidrug-resistant (MDR) TB (strains resistant to at least isoniazid [INH] and rifampin [RIF], the two most important first-line drugs). The spread of MDR strains of Mycobacterium tuberculosis has become a major public health problem (24). Current TB diagnostic tests are expensive (automated liquid-based culture systems and molecular methods) or slow (culture on solid media and biochemical tests). Standard methods for antibiotic susceptibility testing (AST) of M. tuberculosis such as the proportion method and the absoluteconcentration method depend on culture on solid media and are also time-consuming. The BACTEC 460TB system (Becton Dickinson, Sparks, Md.) using liquid media is faster but involves radioactive substrates and expensive technology (17). The radiometric BACTEC 460TB system is being replaced by the BACTEC Mycobacteria Growth Indicator Tube (MGIT) 960 (Becton Dickinson) and MB/Bact (biomérieux, Inc., Durham, N.C.) automated liquid-based systems for detection and AST. The turnaround times for the latter systems are comparable to that for the radiometric BACTEC 460TB system, but reagents for automated systems are expensive. The manual BACTEC MGIT system is nonautomated and thus does not require additional instrumentation (22). Several studies have validated the performance of this system for AST (19, 22). Molecular methods for AST have also been described (14) but need substantial investments in equipment and quality control. A number of low-cost colorimetric AST assays, such as the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay (3, 13), the Alamar blue assay (15), and an assay based on microscopic detection of cord-like growth by M. tuberculosis (4), have been described. However, these tests have limitations; mycobacteria other than M. tuberculosis can produce cord factor (10), and INH can interfere with the formazan production in the MTT assay and give rise to false-resistant results (13). Moreover, the use of a liquid medium in a microtiter plate format in these tests may be disadvantageous not only as a biohazard but also due to possible contamination between wells. Recently, an AST for M. tuberculosis based on a nitrate reductase assay performed in nitrate-containing Löwenstein- Jensen (LJ) solid medium was described (2). The test was comparable to the BACTEC 460TB system in detecting INH and RIF resistance, and the AST results were available in 10 days for 87% of the strains tested (2). In the present study, the nitrate reductase-based test was adapted for use as a colorimetric nitrate reductase-based antibiotic susceptibility (CONRAS) test for M. tuberculosis in Middlebrook 7H9 broth cultures. The method is based on the ability of M. tuberculosis to reduce nitrate to nitrite by using the nitrate reductase enzyme (12). Most apathogenic mycobacteria lack this enzyme. The presence of nitrite is detected by a color change to pink upon the addition of specific reagents. The reduction of nitrate to nitrite was detected visually and, on a subset of samples, also by spectrophotometry. The performance of the CONRAS test was evaluated against those of two commercial liquid-based systems, the radiometric BACTEC 460TB and the manual MGIT, for determining the susceptibilities of 74 M. tuberculosis strains to INH and RIF. (A preliminary report of this work was presented at the 4th World Congress on Tuberculosis, Washington, D.C., 3 to 5 June 2002.) * Corresponding author. Mailing address: Department of Microbiology and Immunology, The Gade Institute and Haukeland University Hospital, University of Bergen, N-5021 Bergen, Norway. Phone: Fax: Harleen.Grewal@cih.uib.no. MATERIALS AND METHODS Strains. A total of 74 M. tuberculosis strains were included in the study. Of these, 21 strains were obtained from the Norwegian Institute of Public Health, Oslo, Norway, 13 strains were obtained from Russia (20), 20 strains (and in 5173
2 5174 SYRE ET AL. J. CLIN. MICROBIOL. addition a panel of duplicates from 18 of these strains) were obtained from the World Health Organization/International Union against Tuberculosis and Lung Disease supranational laboratory network (11), 8 were obtained from Myanmar (16), and 11 were obtained from the Haukeland University Hospital, Bergen, Norway. In addition, the M. tuberculosis strain H37Rv (ATCC 27294) was also included. Forty-two of the strains were susceptible to INH and RIF, whereas 32 strains were resistant to one or both of the drugs (15 were INH resistant, and 17 were resistant to both INH and RIF). The nitrate-positive reference strain M. tuberculosis H37Rv (ATCC 27294) and a nitrate-negative clinical isolate of the Mycobacterium avium-intracellulare complex were used as controls in the CON- RAS test. The 74 M. tuberculosis strains and the panel of 18 duplicates, of which 3 were INH resistant and 7 were resistant to both INH and RIF, were coded and tested blindly. The strains were stored at 70 C and cultured on LJ medium before use. Preparation of inocula for use in the CONRAS test. Several loopfuls of growth from 14-day-old cultures on LJ medium were transferred to sterile tubes with glass beads containing 4 ml of Middlebrook 7H9 broth (Difco, Detroit, Mich.) supplemented with 10% oleic acid-albumin-dextrose-catalase (OADC), 0.5% glycerol, 0.05% Tween 80, and 850 g of NaNO 3 /ml (7H9-S broth). The tubes were vortexed for 2 to 3 min to break up larger clumps. The suspension was allowed to stand for 20 min before transfer of the supernatant to another sterile tube. The supernatant fluid was allowed to stand for another 15 min before transfer of the supernatant to a third sterile tube. The suspensions were then adjusted to turbidities equal to those of no. 0.5 and no. 1 McFarland standards and were used in the CONRAS test. The 1 McFarland standard suspensions were used for rapidly screening the 74 M. tuberculosis strains for nitrate positivity. The test was performed in 110- by 16-mm round-bottom, screw-cap sterile polystyrene tubes (Nunc, Roskilde, Denmark). The purity of each mycobacterial suspension was checked on blood agar plates (Colombia agar base [Oxoid, Basingstoke, England] with 5% sheep blood), which were incubated at 37 C for 48 h. Nitrate reduction test. The nitrate test was performed as described previously (12), with some modifications. Thus, the following reagents were added sequentially to the AST tubes: 25 l of concentrated hydrochloric acid (HCl), 50 l of 0.2% sulfanilamide, and 50 l of 0.1% N-1-naphthyl-ethylenediamine dihydrochloride. The resulting color changes were read visually after 5 min. In addition, on a subset of 24 isolates (of which 8 were INH resistant and 9 were resistant to both INH and RIF), absorbance was recorded using a spectrophotometer at 570 nm (Novaspec II photometer; Pharma Biotech, Cambridge, United Kingdom). In order to detect nitrite that may have been further reduced to nitric oxide (which cannot be detected by the reagents used in the nitrate test), a small amount of powdered zinc (Merck and Co., Inc., Rahway, N.J.) was added to each negative tube to detect false-negative results. Six standard tubes, prepared by serial twofold dilutions of a 1:128 dilution of a nitrite stock solution (10 mm sodium nitrite), were used as reference standards for visually recording color intensity (graded from 1 through 6 ) (Fig. 1A). CONRAS test. The CONRAS test was performed with an initial concentration of 0.1 g/ml for INH and 1.0 g/ml for RIF. If a strain was resistant to an antibiotic by visual recording, the test was repeated with a higher concentration of the drug in question (0.4 g/ml for INH and 2.0 g/ml for RIF). After the code was broken, AST results that were discrepant between the CONRAS test and the BACTEC 460TB system were retested by the CONRAS test. Thus, for each strain tested, panels of 10 tubes with 1 ml of 7H9-S broth were used: 1 tube each with INH and RIF (inoculated with 110 l of the bacterial suspension with a turbidity equal to the no. 0.5 McFarland standard) and 8 tubes without any antibiotic. Three of the antibiotic-free tubes were inoculated with 110 l ofthe bacterial suspension (turbidity equal to the no. 1 McFarland standard), three were inoculated with 110 l of a 1:5 dilution of the bacterial suspension (turbidity equal to the no. 0.5 McFarland standard), and two were inoculated with 110 l of a 1:500 dilution of the bacterial suspension (turbidity equal to the no. 0.5 McFarland standard). A control tube containing 7H9-S broth alone was also included. The tubes were incubated at 37 C with gentle shaking. Thus, for each strain tested, the nitrate test was performed on one 1 McFarland tube every second day, starting on the third day after inoculation. If a color intensity equal to or greater than that of the 4 standard tube was obtained (Fig. 1A), the corresponding 1:5 tube was also tested by the nitrate test. The antibiotic-containing tubes were tested if the color intensity in the 1:5 tube was greater than or equal to that of the 4 standard tube. If the 1:5 tube showed a color intensity less than that of the 4 standard tube, the antibiotic-containing tubes were incubated for an additional two days. In an initial pilot study performed on 30 strains tested for susceptibility to INH and RIF, the cutoff for detection of resistant strains by the CONRAS method was determined. Thus, for visual recording, the color intensity of the 1:500 tube of a strain was compared with the intensity in the color FIG. 1. (A) Serial twofold dilutions of a standard stock solution of sodium nitrite (NaNO 2 ) resulting in an increasing color intensity graded from 1 through 6. (B) Example of a strain examined by the CONRAS test. The color intensity of the 1:500 dilution of the bacterial suspension was compared with the color intensity in the standard tubes (panel A). A strain was considered to be resistant if the color intensity of the antibiotic-containing tube was equal to or greater than two color intensity gradations above that of the 1:500 tube. This strain is resistant to INH. standard tubes. A strain was classified as resistant if the color intensity in the antibiotic-containing tube was 2 color intensity gradations above that of the 1:500 tube. By use of spectrophotometry, a strain was classified as resistant if the antibiotic-containing tube had an optical density at 570 nm (OD 570 ) 0.03 OD unit above the OD 570 recorded in the 1:500 tube. Manual MGIT. AST was performed according to the manufacturer s instructions (BACTEC MicroMGIT; Becton Dickinson). The following critical concentrations were used: 0.1 g/ml for INH and 1.0 g/ml for RIF.
3 VOL. 41, 2003 COLORIMETRIC METHOD FOR DRUG SUSCEPTIBILITY TESTING 5175 TABLE 1. Performance of the CONRAS test compared with the BACTEC 460TB as a reference method for 74 M. tuberculosis strains CONRAS a result No. of isolates with the following BACTEC 460TB b result: INH Susceptible Resistant 2 32 RIF Susceptible Infinite 0.06 Resistant 0 16 a concentrations, 0.4 g/ml for INH and 2.0 g/ml for RIF. b concentrations, 0.2 g/ml for INH and 2.0 g/ml for RIF. Radiometric BACTEC 460TB. Antibiotic susceptibility was determined by standard procedures in a BACTEC 460TB instrument (Becton Dickinson) (17) with the following critical concentrations: 0.2 g/ml for INH and 2.0 g/ml for RIF. Resolution of discrepant results. Strains with AST results that were discrepant between the CONRAS test and the BACTEC 460TB system were retested by additional methods. Thus, the Etest (AB BIODISK, Solna, Sweden) (23) providing quantitative drug susceptibility results for RIF and INH and the INNO- LiPA Rif. TB test (Innogenetics N.V., Ghent, Belgium) were used according to the manufacturers instructions. For determination of susceptibility categories by the Etest, breakpoints of 1 and 0.2 g/ml for RIF and INH, respectively, were utilized (Etest application sheet; AB BIODISK). The INNO-LiPA Rif. TB test identifies mutations associated with RIF resistance in the gene encoding the -subunit of RNA polymerase (rpob) (18). Data analysis. The performance of the CONRAS test and the manual MGIT system in comparison with the BACTEC 460TB system was evaluated in terms of sensitivity, specificity, and positive and negative likelihood ratios for the two drugs tested. A positive likelihood ratio above 10 or a negative likelihood ratio below 0.1 was considered to indicate excellent test-performance, whereas ratios above 5 and below 0.2 were taken to indicate adequate performance (5, 8). The independent sample t test was used to compare the times needed for CONRAS test completion for susceptible versus resistant strains. The agreement between the CONRAS results, the manual MGIT results, and the BACTEC 460TB AST results, as well as CONRAS repeatability, were estimated by the kappa statistic. The kappa value, a measure of test reliability, was interpreted as follows: 0.2, poor; 0.21 to 0.4, fair; 0.41 to 0.6, moderate; 0.61 to 0.8, good; 0.81, excellent (1). Costs. Costs (shipping, custom taxes, and labor not included) were calculated by using purchase records. RESULTS Comparison between CONRAS, manual MGIT, and BACTEC 460TB tests. All 74 M. tuberculosis strains were nitrate positive and were therefore tested for susceptibility to RIF and INH at low antibiotic concentrations by the CONRAS test. Strains that were resistant at the low drug concentrations were tested at high concentrations (39 tests for INH; 22 tests for RIF). The sensitivity (i.e., the ability to detect true drug resistance) and specificity (i.e., the ability to detect true drug susceptibility) of the CONRAS test at low critical concentrations of the drugs, by using the BACTEC 460TB system as the reference, were 100 and 83% for INH and 94 and 89% for RIF, respectively. The corresponding sensitivities and specificities at high antibiotic concentrations were 100 and 95% for INH and 94 and 100% for RIF, respectively (Table 1). At low concentrations, there was excellent agreement for INH and good agreement for RIF between the CONRAS test and the BACTEC 460TB system (kappa values, 0.81 for INH and 0.76 for RIF; P 0.001). However, at high concentrations, there was excellent agreement for both INH and RIF between the two tests (kappa, 0.95 and 0.96, respectively; P 0.001). There were three discordant single-drug susceptibility results between the high-antibiotic-concentration CONRAS test and the BACTEC 460TB system (Table 1). Thus, one strain tested for single-drug susceptibility was determined to be RIF susceptible by the CONRAS test as well as the manual MGIT test but was resistant by the BACTEC 460TB system (the strain was resistant to INH by all three methods). A repeat CONRAS test confirmed the original result. The Etest showed that the RIF MIC for the strain was 0.38 g/ml. The INNO- LiPA Rif. TB test classified the strain as RIF resistant ( S2 mutation). Furthermore, two strains tested for single-drug susceptibility were determined to be resistant in both low and high concentrations of INH by the CONRAS test but were susceptible in the BACTEC 460TB system (both strains were susceptible to RIF). The Etest confirmed that the strains were susceptible to INH (MIC, g/ml). There were seven discordant single-drug susceptibility results between the manual MGIT and the BACTEC 460TB TABLE 2. Performance of the manual MGIT compared with the BACTEC 460TB as a reference method for 74 M. tuberculosis strains MGIT a result No. of isolates with the following BACTEC 460TB b result: INH Susceptible Resistant 4 32 RIF Susceptible Infinite 0.18 Resistant 0 14 a concentrations, 0.1 g/ml for INH and 1.0 g/ml for RIF. b concentrations, 0.2 g/ml for INH and 2.0 g/ml for RIF.
4 5176 SYRE ET AL. J. CLIN. MICROBIOL. TABLE 3. Performance of the CONRAS test compared with the manual MGIT as a reference method for 74 M. tuberculosis strains CONRAS a result No. of isolates with the following manual MGIT b result: INH Susceptible Resistant 1 33 RIF Susceptible Resistant 2 14 a concentrations, 0.4 g/ml for INH and 2.0 g/ml for RIF. b concentrations, 0.1 g/ml for INH and 1.0 g/ml for RIF. system (Table 2). Three strains tested for single-drug susceptibility were characterized as susceptible for RIF by the manual MGIT but as resistant by the BACTEC 460TB system (Table 2). Four strains tested for single-drug susceptibility were determined to be INH resistant by the manual MGIT but were susceptible in the BACTEC 460TB system (Table 2). There was excellent agreement between the manual MGIT system and the BACTEC 460TB system for INH and RIF (kappa, 0.89 and 0.88, respectively; P 0.001). There were six discordant single-drug susceptibility results between the CONRAS test and the manual MGIT (Table 3), and the agreement between the two tests for INH and RIF was excellent (kappa, 0.89 and 0.92, respectively; P for both). Spectrophotometric reading. Susceptibility results were also recorded spectrophotometrically on a subset of 24 isolates. Excellent agreement was achieved between the spectrophotometric and visual recordings of the CONRAS test when high concentrations of RIF and INH were used (kappa, 1 and 0.89, respectively; P for both). Repeatability. The repeatability of the CONRAS test as determined in the panel of 18 duplicates was 100% (18 of 18) for INH and 94% (17 of 18) for RIF. The repeatability of the CON- RAS test for the two key anti-tb drugs was excellent (for INH, kappa 1 and P 0.001; for RIF, kappa 0.88 and P 0.001). Turnaround time. Nitrite production increased rapidly during the first 3 days of growth and reached a plateau after day 5 (Fig. 2). The average time required for obtaining a susceptibility result by the CONRAS test was 5.4 days (range, 3 to 9), compared to 5.1 days (range, 5 to 8) for the BACTEC 460TB and 5.0 days (range, 5 to 6) for the manual MGIT system. Susceptibility results by the CONRAS test were available in 5 days for 66% of the strains, in 7 days for 93% of the strains, and in 9 days for 100% of the strains. The results for fully susceptible strains were significantly likely to be available before those for strains with any resistance (means, 4.9 and 5.7 days, respectively; P 0.001). possess nitrate reductase and are capable of reducing nitrate to nitrite. Some other mycobacterial species (M. kansasii, M. smegmatis, M. flavescens, and M. fortuitum) also possess this enzyme. However, these strains are not frequently encountered in human infections, and they can be identified by morphological and biochemical tests. It has been shown that the peak in the nitrate reductase activity of M. tuberculosis takes place after 3 to 4 weeks of bacterial incubation in LJ medium (12). The time to achieve peak activity can be considerably shortened by growing the bacterium in a liquid medium (Fig. 2). The CONRAS test was evaluated against two commercial systems: the radiometric BACTEC 460TB semiautomated system (Table 1) and the manual liquid system (MGIT) (Table 3). Seventy-four M. tuberculosis strains, including 20 well-characterized strains, and, in addition, a panel of 18 duplicates (to assess repeatability) were used in the evaluation. The average time for a susceptibility result by the CONRAS test was 5.4 days, which was comparable to turnaround times for the BACTEC 460TB and manual MGIT systems. The repeatability of the CONRAS test for the two key anti-tb drugs was excellent. Susceptibility data obtained by the CONRAS method for these drugs compared excellently with those from the BACTEC 460TB (Table 1) and manual MGIT (Table 3), suggesting that the CONRAS method is useful in providing rapid and reliable AST results for these antibiotics. Previous studies have shown that the manual MGIT is a reliable, rapid, DISCUSSION Rapid AST results for M. tuberculosis are a prerequisite for initiating effective anti-tb treatment. Rapid and low-cost AST procedures for the testing of INH and RIF, the two anti-tb drugs that define MDR TB, are urgently needed, particularly in poor countries where TB is endemic. In this study, we describe the evaluation of a nitrate reductasebased assay in a liquid medium as a rapid and reliable AST for RIF and INH. More than 99% (9) of M. tuberculosis strains FIG. 2. Nitrite production (y axis) measured in 24 M. tuberculosis strains during 2 weeks growth in Middlebrook 7H9 broth with supplements.
5 VOL. 41, 2003 COLORIMETRIC METHOD FOR DRUG SUSCEPTIBILITY TESTING 5177 and convenient method for performing AST; however, cost is a factor prohibiting widespread implementation of this test (6, 19, 22). This study shows that the CONRAS test matches the manual MGIT system in the reliability of susceptibility results and the turnaround time. The CONRAS test was first performed at low concentrations of the antibiotics, and strains that were found resistant at these concentrations were then retested at high antibiotic concentrations. The overall agreement of the CONRAS test with the BACTEC 460TB system was 91% (134 out of 148 drug susceptibility tests) when the strains were tested at low antibiotic concentrations and 98% (145 out of 148 tests) when the resistant strains were retested with the high concentration of the antibiotic in question (Table 1). Thus, it is recommended that the CONRAS test be performed using critical concentrations of 0.4 g/ml for INH and 2.0 g/ml for RIF. The emergence of MDR strains of M. tuberculosis poses a serious problem in TB control. Resistance to RIF is almost always associated with MDR (21). Thus, RIF resistance can serve as a surrogate marker for the detection of MDR strains in resourcepoor settings. In our study, there were 17 strains that were resistant to both INH and RIF. The CONRAS assay correctly identified 16 of these 17 strains. The remaining strain was resistant to INH and RIF by the BACTEC 460TB system but was susceptible to RIF by the CONRAS test and the manual MGIT method. The sensitivity of the CONRAS test depends on the metabolic activity of viable cells in order to achieve measurable nitrate reduction. It has been suggested that drug-resistant isolates may have lower metabolic activity (7); for example, rpob mutations leading to RIF resistance might affect the expression levels of particular enzymes. This strain could have a low level of resistance that could not be detected by the CONRAS test or the manual MGIT. This assumption was corroborated by the Etest, which revealed that the MIC for the strain was 0.38 g/ml, i.e., close to the breakpoint between susceptible and resistant strains (the RIF MIC range for the fully susceptible strain H37RV is 0.06 to 0.25) (23). The INNO-LiPA test revealed that the strain had a relatively uncommon resistant genotype ( S2 mutation in the rpob gene) (18). There was excellent agreement between the visual and spectrophotometric recording of AST results by the CONRAS method for both drugs. Thus, the CONRAS test is not particularly vulnerable to observer misinterpretation, and visual recording of results can replace spectrophotometric readings. We calculated the cost for AST by the CONRAS test for the two first-line anti-tb drugs per strain to be approximately U.S. $3. This is substantially less expensive than the BACTEC 460TB (U.S. $21) and the manual MGIT system (U.S. $23). Thus, the CONRAS test is a cheap and reliable alternative for the rapid detection of MDR TB. ACKNOWLEDGMENTS We thank E. Ulvestad for providing excellent laboratory facilities, H. Sommerfelt and A. Digranes for valuable comments, and E. Rønnild and H. Valvatne for assistance in the laboratory. This study was funded in part by the Norwegian Research Council, University of Bergen, and the Meltzer Høyskolefond. REFERENCES 1. Altman, D. G Inter-rater agreement, p In D. G. Altman (ed.), Practical statistics for medical research. Chapman & Hall/CRC, London, United Kingdom. 2. Ängeby, K. A. K., L. Klintz, and S. E. Hoffner Rapid and inexpensive drug susceptibility testing of Mycobacterium tuberculosis with a nitrate reductase assay. J. Clin. Microbiol. 40: Caviedes, L., J. Delgado, and R. H. Gilman Tetrazolium microplate assay as a rapid and inexpensive colorimetric method for determination of antibiotic susceptibility of Mycobacterium tuberculosis. J. Clin. Microbiol. 40: Caviedes, L., T. Lee, R. H. Gilman, P. Sheen, E. Spellman, E. H. Lee, D. E. Berg, S. Montenegro-James, and The Tuberculosis Working Group in Peru Rapid, efficient detection and drug susceptibility testing of Mycobacterium tuberculosis in sputum by microscopic observation of broth cultures. J. Clin. Microbiol. 38: Deeks, J. J Systematic reviews of evaluations of diagnostic and screening tests. BMJ 323: Goloubeva, V., M. Lecocq, P. Lassowsky, F. Matthys, F. Portaels, and I. Bastian Evaluation of Mycobacteria Growth Indicator Tube for direct and indirect drug susceptibility testing of Mycobacterium tuberculosis from respiratory specimens in a Siberian prison hospital. J. Clin. Microbiol. 39: Inderlied, C. B., and M. Salfinger Antimycobacterial agents and susceptibility test, p In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 7th ed. American Society for Microbiology, Washington, D.C. 8. Jaeschke, R., G. H. Guyatt, D. L. Sackett, et al Users guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? JAMA 271: Kent, P. T., and G. P. Kubica Public health mycobacteriology. A guide for the level III laboratory, p U.S. Department of Health and Human Services, Atlanta, Ga. 10. Kilburn, J. O., and K. Takayama Effects of ethambutol on accumulation and secretion of trehalose mycolates and free mycolic acids in Mycobacterium smegmatis. Antimicrob. Agents Chemother. 20: Laszlo, A., M. Rahman, M. Raviglione, and F. Bustreo Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Laboratory Network: first round of proficiency testing. Int. J. Tuberc. Lung Dis. 2: Master, R. N Identification tests for mycobacteria, part 3.122, p In H. O. Isenberg (ed.), Clinical microbiology procedures handbook, vol. 1. American Society for Microbiology, Washington, D.C. 13. Mshana, R. N., G. Tadesse, G. Abate, and H. Miørner Use of 3-(4,5- dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide for rapid detection of rifampin-resistant Mycobacterium tuberculosis. J. Clin. Microbiol. 36: Nachamkin, I., C. Kang, and M. P. Weinstein Detection of resistance to isoniazid, rifampin, and streptomycin in clinical isolates of Mycobacterium tuberculosis by molecular methods. Clin. Infect. Dis. 24: Palomino, J. C., and F. Portaels Simple procedure for drug susceptibility testing of Mycobacterium tuberculosis using a commercial colorimetric assay. Eur. J. Clin. Microbiol. Infect. Dis. 18: Phyu, S., T. Ti, R. Jureen, T. Mmun, H. Myint, A. Tun, H. M. S. Grewal, and B. Bjorvatn resistant tuberculosis among new patients in Yangon, Myanmar. Emerg. Infect. Dis. 9: Roberts, G. D., N. L. Goodman, L. Heifets, H. W. Larsh, T. H. Linder, J. K. McClatchy, M. R. McGinnis, S. H. Siddiqi, and P. Wright Evaluation of the BACTEC radiometric method for recovery of mycobacteria and drug susceptibility testing of Mycobacterium tuberculosis from acid-fast smearpositive specimens. J. Clin. Microbiol. 18: Rossau, R., H. Traore, H. De Beenhouwer, W. Mijs, G. Jannes, P. De Rijk, and F. Portaels Evaluation of the INNO-LiPA Rif. TB assay, a reverse hybridization assay for the simultaneous detection of Mycobacterium tuberculosis complex and its resistance to rifampin. Antimicrob. Agents Chemother. 41: Rüsch-Gerdes, S., C. Domehl, G. Nardi, M. R. Gismondo, H.-M. Welscher, and G. E. Pfyffer Multicenter evaluation of the mycobacterial growth indicator tube for testing susceptibility of Mycobacterium tuberculosis to first-line drugs. J. Clin. Microbiol. 37: Toungoussova, O. S., P. Sandven, A. O. Mariandyshev, N. I. Nizovtseva, G. Bjune, and D. A. Caugant Spread of drug-resistant Mycobacterium tuberculosis strains of the Beijing genotype in the Archangel Oblast, Russia. J. Clin. Microbiol. 40: Vareldzis, B. P., J. Grosset, I. De Kantor, J. Crofton, A. Laszlo, M. Felten, M. C. Raviglione, and A. Kochi resistant tuberculosis: laboratory issues. World Health Organization recommendations. Tuber. Lung Dis. 75: Walters, S. B., and B. A. Hanna Testing of susceptibility of Mycobacterium tuberculosis to isoniazid and rifampin by mycobacterium growth indicator tube method. J. Clin. Microbiol. 34: Wanger, A., and K. Mills Testing of Mycobacterium tuberculosis susceptibility to ethambutol, isoniazid, rifampin, and streptomycin by using Etest. J. Clin. Microbiol. 34: World Health Organization. Global tuberculosis control: surveillance, planning, financing. WHO Report WHO/CDS/TB/ World Health Organization, Geneva, Switzerland.
Evaluation of the Microscopic-Observation. Drug-Susceptibility Assay Drugs Concentration for Detection Of Multidrug-Resistant Tuberculosis
Evaluation of the Microscopic-Observation Drug-Susceptibility Assay Drugs Concentration for Detection Of Multidrug-Resistant Tuberculosis ABSTRACT New diagnostic tools are urgently needed to interrupt
More informationReceived 22 September 2000/Returned for modification 29 December 2000/Accepted 29 January 2001
JOURNAL OF CLINICAL MICROBIOLOGY, Apr. 2001, p. 1501 1505 Vol. 39, No. 4 0095-1137/01/$04.00 0 DOI: 10.1128/JCM.39.4.1501 1505.2001 Copyright 2001, American Society for Microbiology. All Rights Reserved.
More informationEvaluation of Microscopic Observation Drug Susceptibility Assay (MODS) For the. Detection of Multidrug-Resistant Tuberculosis (MDR-TB) ACCEPTED
JCM Accepts, published online ahead of print on 24 January 2007 J. Clin. Microbiol. doi:10.1128/jcm.01949-06 Copyright 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All
More informationRapid detection of multidrug-resistant Mycobacterium tuberculosis using the mycobacteria growth indicator tube (MGIT) system
Brazilian Journal of Medical and Biological Research (2002) 35: 1127-1131 MGIT detection of multidrug-resistant M. tuberculosis ISSN 0100-879X 1127 Rapid detection of multidrug-resistant Mycobacterium
More informationRapid, Low-Technology MIC Determination with Clinical Mycobacterium tuberculosis Isolates by Using the Microplate Alamar Blue Assay
JOURNAL OF CLINICAL MICROBIOLOGY, Feb. 1998, p. 362 366 Vol. 36, No. 2 0095-1137/98/$04.00 0 Copyright 1998, American Society for Microbiology Rapid, Low-Technology MIC Determination with Clinical Mycobacterium
More informationTB 101 Disease, Clinical Assessment and Lab Testing
TB 101 Disease, Clinical Assessment and Lab Testing Pacific Islands Tuberculosis Controllers Association Conference (PITCA) Clinical Laboratory Breakout None Disclosure Objectives Be able to list and explain
More informationEvaluation of the Performance of Nitrate Reductase Assay for Rapid Drug-susceptibility Testing of Mycobacterium tuberculosis in North India
J HEALTH POPUL NUTR 2011 Feb;29(1):20-25 ISSN 1606-0997 $ 5.00+0.20 INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH, BANGLADESH Evaluation of the Performance of Nitrate Reductase Assay for Rapid Drug-susceptibility
More informationOverview of Mycobacterial Culture, Identification, and Drug Susceptibility Testing
Overview of Mycobacterial Culture, Identification, and Drug Susceptibility Testing 1. Essentials for the Mycobacteriology Laboratory: Promoting Quality Practices 1.1 Overview: Mycobacterial Culture, Identification,
More informationSaid et al. BMC Infectious Diseases 2012, 12:369
Said et al. BMC Infectious Diseases 2012, 12:369 RESEARCH ARTICLE Open Access Comparison between the BACTEC MGIT 960 system and the agar proportion method for susceptibility testing of multidrug resistant
More informationTuberculosis Reference Laboratory, NIDCH, Mahakhali, Dhaka.
Bangladesh J Med Microbiol 2011; 05 (02): 06-10 Bangladesh Society of Medical Microbiologists Original Article A rapid Drug Susceptibility Test (DST) for detection of Multi-Drug Resistant (MDR) Mycobacterium
More informationUse of 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyl Tetrazolium Bromide for Rapid Detection of Rifampin-Resistant Mycobacterium tuberculosis
JOURNAL OF CLINICAL MICROBIOLOGY, May 1998, p. 1214 1219 Vol. 36, No. 5 0095-1137/98/$04.00 0 Copyright 1998, American Society for Microbiology Use of 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyl Tetrazolium
More informationEvaluation of 2,3,5 Triphenyl tetrazolium chloride (TTC) assay for drug susceptibility testing of M. tuberculosis
Original Research Article DOI: 10.18231/2394-5478.2017.0021 Evaluation of 2,3,5 Triphenyl tetrazolium chloride (TTC) assay for drug susceptibility testing of M. tuberculosis Mangala Ghatole 1,*, Virendra
More informationDiagnosis of drug resistant TB
Diagnosis of drug resistant TB Megan Murray, MD, ScD Harvard School of Public Health Brigham and Women s Hospital Harvard Medical School Broad Institute Global burden of TB 9 million new cases year 2 million
More informationMIC = Many Inherent Challenges Sensititre MIC for Antimicrobial Susceptibility Testing of Mycobacterium tuberculosis complex
MIC = Many Inherent Challenges Sensititre MIC for Antimicrobial Susceptibility Testing of Mycobacterium tuberculosis complex Marie Claire Rowlinson, PhD D(ABMM) Florida Bureau of Public Health Laboratories
More informationThe MODS Assay for Detection of TB and TB Drug Resistance: A Multi-center Study
The MODS Assay for Detection of TB and TB Drug Resistance: A Multi-center Study microscopic observation drug susceptibility Susan E. Dorman, MD Johns Hopkins University Afranio L. Kritski, MD, PhD Federal
More informationDrug susceptibility testing for tuberculosis KRISTEN DICKS, MD, MPH DUKE UNIVERSITY MEDICAL CENTER
Drug susceptibility testing for tuberculosis KRISTEN DICKS, MD, MPH DUKE UNIVERSITY MEDICAL CENTER Outline Drug resistant TB: definitions and epidemiology How does TB become resistant? Current drug susceptibility
More informationJAC Comparison of the in vitro activities of rifapentine and rifampicin against Mycobacterium tuberculosis complex
Journal of Antimicrobial Chemotherapy (2000) 46, 571 575 JAC Comparison of the in vitro activities of rifapentine and rifampicin against Mycobacterium tuberculosis complex Pascale Bemer-Melchior a *, André
More informationRapid Diagnosis of Tuberculosis and Multidrug Resistance Using a MGIT 960 System
Original Article Clinical Microbiology Ann Lab Med 2012;32:264-269 ISSN 2234-3806 eissn 2234-3814 Rapid Diagnosis of Tuberculosis and Multidrug Resistance Using a MGIT 960 System Won-Jung Koh, M.D. 1,
More informationReceived 6 May 2006/Returned for modification 2 June 2006/Accepted 23 October 2006
JOURNAL OF CLINICAL MICROBIOLOGY, Jan. 2007, p. 76 80 Vol. 45, No. 1 0095-1137/07/$08.00 0 doi:10.1128/jcm.00951-06 Copyright 2007, American Society for Microbiology. All Rights Reserved. Comparative Evaluation
More informationResearch Article Factors Associated with Missed Detection of Mycobacterium tuberculosis by Automated BACTEC MGIT 960 System
BioMed Research International Volume 2016, Article ID 5972021, 4 pages http://dx.doi.org/10.1155/2016/5972021 Research Article Factors Associated with Missed Detection of Mycobacterium tuberculosis by
More informationLABORATORY BASED DST FOR BEDAQUILINE AND INTRODUCTION IN COUNTRIES
LABORATORY BASED DST FOR BEDAQUILINE AND INTRODUCTION IN COUNTRIES NDWG Annual meeting 2015, Cape Town, South Africa Rigouts Leen, Institute of Tropical Medicine, Antwerp, Belgium 1 Bedaquiline (BDQ) Sirturo
More informationReceived 1 December 2003/Returned for modification 27 January 2004/Accepted 14 May 2004
JOURNAL OF CLINICAL MICROBIOLOGY, Oct. 2004, p. 4432 4437 Vol. 42, No. 10 0095-1137/04/$08.00 0 DOI: 10.1128/JCM.42.10.4432 4437.2004 Copyright 2004, American Society for Microbiology. All Rights Reserved.
More informationINTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE
INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE MYCOBACTERIUM GROWTH INDICATOR TUBE (MGIT) IN COMPARISON TO LOWENSTEIN JENSEN S MEDIUM FOR ISOLATION OF MYCOBACTERIUM SPECIES FROM URINE
More informationMycobacterium tuberculosis Strains with Highly Discordant Rifampin Susceptibility Test Results
JOURNAL OF CLINICAL MICROBIOLOGY, Nov. 2009, p. 3501 3506 Vol. 47, No. 11 0095-1137/09/$12.00 doi:10.1128/jcm.01209-09 Copyright 2009, American Society for Microbiology. All Rights Reserved. Mycobacterium
More informationDirect drug susceptibility testing of Mycobacterium tuberculosis against primary anti-tb drugs in northern India
Original Article Direct drug susceptibility testing of Mycobacterium tuberculosis against primary anti-tb drugs in northern India Anamika Gupta and Shampa Anupurba Department of Microbiology, Institute
More informationComparison of mechanical disruption techniques for the rapid inactivation of
JCM Accepted Manuscript Posted Online 10 August 2016 J. Clin. Microbiol. doi:10.1128/jcm.01096-16 Copyright 2016, American Society for Microbiology. All Rights Reserved. 1 2 3 4 5 6 7 8 9 10 Comparison
More informationRapid detection of mutations in rpob gene of rifampicin resistant Mycobacterium tuberculosis strains by line probe assay
Indian J Med Res 117, February 2003, pp 76-80 Rapid detection of mutations in rpob gene of rifampicin resistant Mycobacterium tuberculosis strains by line probe assay Meera Sharma, Sunil Sethi, Baijayantimala
More informationJillian Dormandy, BS; Akos Somoskovi, MD, PhD; Barry N. Kreiswirth, PhD; Jeffrey R. Driscoll, PhD; David Ashkin, MD; and Max Salfinger, MD
Original Research LUNG INFECTION Discrepant Results Between Pyrazinamide Susceptibility Testing by the Reference BACTEC 460TB Method and pnca DNA Sequencing in Patients Infected With Multidrug-Resistant
More informationMicroscopic Morphology in Smears Prepared from MGIT Broth Medium for Rapid Presumptive Identification of Mycobacterium tuberculosis
Annals of Clinical & Laboratory Science, vol. 33, no. 2, 2003 179 Microscopic Morphology in Smears Prepared from MGIT Broth Medium for Rapid Presumptive Identification of Mycobacterium tuberculosis complex,
More informationStacy White, PhD May 12, TB for Community Providers. Phoenix, Arizona
Role of the Laboratory in TB Diagnosis Stacy White, PhD May 12, 2015 TB for Community Providers May 12, 2015 Phoenix, Arizona EXCELLENCE EXPERTISE INNOVATION Stacy White, PhD has the following disclosures
More informationMycobacterial cell wall. Cell Cycle Lengths. Outline of Laboratory Methods. Laboratory Methods
Laboratory Methods Cell Cycle Lengths Generation time (hrs) Days needed for 26 generations (colony) E. coli 0.33 0.36 Nancy Connell, PhD Professor, nfectious Disease Department of Medicine Center for Emerging
More informationRecent Advances in the Laboratory Detection of Mycobacterium tuberculosis Complex and Drug Resistance
MEDICAL MICROBIOLOGY L. Barth Reller and Melvin P. Weinstein, Section Editors INVITED ARTICLE Recent Advances in the Laboratory Detection of Mycobacterium tuberculosis Complex and Drug Resistance Michael
More informationMolecular tests for rapid detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis.
Title Molecular tests for rapid detection of rifampicin and isoniazid resistance in Mycobacterium. Author(s) Ho, PL; Yam, WC; Leung, CC; Yew, WW; Mok, TYW; Chan, KS; Tam, CM Citation Hong Kong Medical
More informationEVALUATION OF THE BACTEC MGIT 960 TB SYSTEM FOR RECOVERY
Indian Journal of Medical Microbiology, (2009) 27(3): 217-21 Original Article EVALUATION OF THE BACTEC MGIT 960 TB SYSTEM FOR RECOVERY AND IDENTIFICATION OF MYCOBACTERIUM TUBERCULOSIS COMPLEX IN A HIGH
More informationAnti-tuberculosis drug resistance in the world and rapid diagnosis of tuberculosis
Anti-tuberculosis drug resistance in the world and rapid diagnosis of tuberculosis Chiyoji ABE acquired drug resistance primary drug resistance 10 10 HIV 1 3 INHRFP MDR-TB DOTSDirectly Observed Treatment,
More informationTB Laboratory for Nurses
TB Laboratory for Nurses Shea Rabley, RN, MN Consultant Mayo Clinic Center for Tuberculosis 2014 MFMER slide-1 Disclosures None 2014 MFMER slide-2 Objectives Participants will be able to: 1. Name 2 safety
More informationUse of BACTEC MGIT 960 for Recovery of Mycobacteria from Clinical Specimens: Multicenter Study
JOURNAL OF CLINICAL MICROBIOLOGY, Nov. 1999, p. 3578 3582 Vol. 37, No. 11 0095-1137/99/$04.00 0 Copyright 1999, American Society for Microbiology. All Rights Reserved. Use of BACTEC MGIT 960 for Recovery
More informationCOMPARATIVE EVALUATION OF BACTEC 460TB SYSTEM AND LOWENSTEIN-JENSEN MEDIUM FOR THE ISOLATION OF M. TUBERCULOSIS
236 Indian Journal of Medical Microbiology, (2007) 25 Indian (3):236-40 Journal of Medical Microbiology vol. 25, No. 3 Original Article COMPARATIVE EVALUATION OF BACTEC 460TB SYSTEM AND LOWENSTEIN-JENSEN
More informationDRUG RESISTANCE IN TUBERCULOSIS
DRUG RESISTANCE IN TUBERCULOSIS INTRODUCTION Up to 50 million people may be infected with drug-resistant resistant TB.* Hot zones of MDR-TB such as Russia, Latvia, Estonia, Argentina and the Dominican
More informationReceived 29 January 2003/Returned for modification 10 March 2003/Accepted 14 April 2003
JOURNAL OF CLINICAL MICROBIOLOGY, July 2003, p. 2822 2826 Vol. 41, No. 7 0095-1137/03/$08.00 0 DOI: 10.1128/JCM.41.7.2822 2826.2003 Copyright 2003, American Society for Microbiology. All Rights Reserved.
More informationLaboratory Diagnostic Techniques. Hugo Donaldson Consultant Microbiologist Imperial College Healthcare NHS Trust
Laboratory Diagnostic Techniques Hugo Donaldson Consultant Microbiologist Imperial College Healthcare NHS Trust Learning Objectives 1) When to consider a diagnosis of TB 2) When to consider a referral
More informationMODS KIT ti A Culture of Service
101311ti A ulture of Service Microscopic Observation Drug Susceptibility Assay A standardized and accelerated liquid culture and direct susceptibility testing method for Mycobacterium tuberculosis. One-third
More informationNTM Mycobacterium avium Mycobacterium intracellulare Complex
2006 67 NTM Mycobacterium aviummycobacterium intracellulare Complex 1) 1) 1) 1) 2) 1) 2) 17 8 29 18 2 9 Mycobacterium avium Mycobacterium intracellulare 6 MIC NTM MIC 1 3 NTM 5 MIC MIC M. avium 1 M. intracellulare
More informationIn-vitro susceptibility of Mycobacterium tuberculosis to trimethoprim and. sulfonamides, France
AAC Accepts, published online ahead of print on 23 September 2013 Antimicrob. Agents Chemother. doi:10.1128/aac.01683-13 Copyright 2013, American Society for Microbiology. All Rights Reserved. 1 2 In-vitro
More informationCDPH - CTCA Joint Guidelines Guideline for Micobacteriology Services In California
CDPH - CTCA Joint Guidelines Guideline for Micobacteriology Services In California These guidelines are intended to be used as an educational aid to help clinicians make informed decisions about patient
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Cain KP, McCarthy KD, Heilig CM, et al. An algorithm for tuberculosis
More informationKen Jost, BA, has the following disclosures to make:
Diagnosis of TB Disease: Laboratory Ken Jost, BA May 10, 2017 TB Intensive May 9-12, 2017 San Antonio, TX EXCELLENCE EXPERTISE INNOVATION Ken Jost, BA, has the following disclosures to make: No conflict
More informationFrances Morgan, PhD October 21, Comprehensive Care of Patients with Tuberculosis and Their Contacts October 19 22, 2015 Wichita, KS
The Laboratory s Role in Caring for Patients Diagnosed with TB Frances Morgan, PhD October 21, 2015 Comprehensive Care of Patients with Tuberculosis and Their Contacts October 19 22, 2015 Wichita, KS EXCELLENCE
More informationResearch Article Use of Genotype MTBDRplus Assay for Diagnosis of Multidrug-Resistant Tuberculosis in Nepal
Hindawi International Scholarly Research Notices Volume 2017, Article ID 1635780, 5 pages https://doi.org/10.1155/2017/1635780 Research Article Use of Genotype MTBDRplus Assay for Diagnosis of Multidrug-Resistant
More informationMolecular diagnosis of MDR-TB using GenoType MTBDRplus 96 assay in Ibadan, Nigeria
Niger. J. Physiol. Sci. 28(December 2013) 187 191 www.njps.com.ng Molecular diagnosis of MDR-TB using GenoType MTBDRplus 96 assay in Ibadan, Nigeria * 1 Kehinde A.O. and 2 Adebiyi, E.O. Department of Medical
More informationPelin Yuksel*, Suat Saribas and Yasar Bagdatli
African Journal of Microbiology Research Vol. 5(9), pp. 985-989, 4 May, 2011 Available online http://www.academicjournals.org/ajmr DOI: 10.5897/AJMR10.008 ISSN 1996-0808 2011 Academic Journals Full Length
More informationComparison of recoveries of Mycobacterium tuberculosis using the automated BACTEC MGIT 960 System and Lowenstein Jensen medium
Comparison of recoveries of Mycobacterium tuberculosis using the automated System and Lowenstein Jensen medium Mo. A.AL-Mazini T. Bukeet A. Abdul Kareem Coll. of Sci./ Unive Basrah Abstract We examined
More informationAFB Identification Texas Approach
AFB Identification Texas Approach Ken Jost Texas Department of State Health Services 6th National Conference on Laboratory Aspects of TB June 21, 2010 DSHS-Austin TB Lab Customers & Samples Year 2009 175
More informationTuberculosis in Greece: bacteriologically confirmed cases and anti-tuberculosis drug resistance,
Surveillance and outbreak reports Tuberculosis in Greece: bacteriologically confirmed cases and anti-tuberculosis drug resistance, 1995-2009 D Papaventsis (dpapaventsis@yahoo.gr) 1, S Nikolaou 1, S Karabela
More informationMULTIDRUG- RESISTANT TUBERCULOSIS. Dean Tsukayama Hennepin County Medical Center Hennepin County Public Health Clinic
MULTIDRUG- RESISTANT TUBERCULOSIS Dean Tsukayama Hennepin County Medical Center Hennepin County Public Health Clinic I have no relevant financial relationships. Discussion includes off label use of: amikacin
More informationObjectives. TB Laboratory Methods
TB Laboratory Methods Beverly Metchock, Dr.P.H., D(ABMM) Team Leader, Reference Laboratory, Mycobacteriology Laboratory Branch February 2011 Objectives General overview of mycobacteriology (TB) lab practices
More informationWhen good genes go bad
When good genes go bad Dr Kessendri Reddy NHLS Tygerberg Hospital Division of Clinical Microbiology Fakulteit Geneeskunde en Gesondheidswetenskappe Faculty of Medicine and Health Sciences Overview Cases
More informationWELCOME. Lab Talk: What a Nurse Hears. April 18, NTNC Annual Meeting Lab Talk: What a Nurse Hears
Lab Talk: What a Lab Talk: What a Max Salfinger, MD, FIDSA, FAAM Executive Director, Advanced Diagnostic Laboratories Laboratory Director, Mycobacteriology & Pharmacokinetics National Jewish Health Lisa
More informationKekkaku Vol. 79, No. 11: ,
Kekkaku Vol. 79, No. 11:625-630, 2004 625 Reproducibility of MGIT 960 AST/M.Tomita et al. 627 Table 2 BACTEC MGIT 960 AST set inoculum from positive MGIT culture ( n=15) Table 3 Days required for BACTEC
More informationRapid Diagnosis and Detection of Drug Resistance in Tuberculosis
Rapid Diagnosis and Detection of Drug Resistance in Tuberculosis YAM Wing-Cheong 任永昌 Department of Microbiology The University of Hong Kong Tuberculosis Re-emerging problem in industrialized countries
More informationMycobacteriology Unit, Institute of Tropical Medicine, Nationalestraat 155, 2000
JCM Accepts, published online ahead of print on 16 September 2009 J. Clin. Microbiol. doi:10.1128/jcm.01209-09 Copyright 2009, American Society for Microbiology and/or the Listed Authors/Institutions.
More informationA NOVEL PHARMACODYNAMIC MODEL FOR TREATMENT OF TUBERCULOSIS USING DAYS TO POSITIVITY IN AUTOMATED LIQUID MYCOBACTERIAL CULTURE
A NOVEL PHARMACODYNAMIC MODEL FOR TREATMENT OF TUBERCULOSIS USING DAYS TO POSITIVITY IN AUTOMATED LIQUID MYCOBACTERIAL CULTURE Emmanuel Chigutsa 1, Kashyap Patel 2, Marianne Visser 3, Gary Maartens 1,
More informationAn Integrated Approach to Rapid Diagnosis of Tuberculosis and Multidrug Resistance Using Liquid Culture and Molecular Methods in Russia
An Integrated Approach to Rapid Diagnosis of Tuberculosis and Multidrug Resistance Using Liquid Culture and Molecular Methods in Russia Yanina Balabanova 1,2 *, Francis Drobniewski 1, Vladyslav Nikolayevskyy
More informationDiagnosis of TB: Laboratory Ken Jost Tuesday April 9, 2013
TB Nurse Case Management San Antonio, Texas April 9-11, 2013 Diagnosis of TB: Laboratory Ken Jost Tuesday April 9, 2013 Ken Jost has the following disclosures to make: No conflict of interests No relevant
More informationTuberculosis Drug Resistance: An Overview
Human Journals Review Article November 2015 Vol.:1, Issue:2 All rights are reserved by Prasanna Mahendra Sapkal et al. Tuberculosis Drug Resistance: An Overview Keywords: Drug resistance mechanisms, Anti-tuberculosis
More informationNitrate reductase assay for rapid detection of isoniazid, rifampicin, ethambutol and
JCM Accepts, published online ahead of print on 16 October 2013 J. Clin. Microbiol. doi:10.1128/jcm.01990-13 Copyright 2013, American Society for Microbiology. All Rights Reserved. 1 2 3 Nitrate reductase
More informationUC Berkeley UC Berkeley Previously Published Works
UC Berkeley UC Berkeley Previously Published Works Title A commercial line probe assay for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis
More informationPrinciples of laboratory diagnosis of M. tuberculosis. Anne-Marie Demers, MD, FRCPC 11 September 2017
Principles of laboratory diagnosis of M. tuberculosis Anne-Marie Demers, MD, FRCPC 11 September 2017 QUESTION Which statement is false? 1) A smear can only be on a concentrated specimen 2) It is normal
More informationTB Intensive San Antonio, Texas November 11 14, 2014
TB Intensive San Antonio, Texas November 11 14, 2014 Diagnosis of TB: Laboratory Ken Jost, BA November 12, 2014 Ken Jost, BA has the following disclosures to make: No conflict of interests No relevant
More informationReceipt within 1 day of specimen collection. Report AFB b smear result within 1 day from receipt of specimen
Recommendation Promote rapid delivery of specimens to the laboratory Use fluorescent acid-fast staining and promptly transmit results by phone, FAX, or electronically Identify growth as acid-fast and use
More informationIn Vitro Interactions between New Antitubercular Drug Candidates SQ109 and TMC207
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, July 2010, p. 2840 2846 Vol. 54, No. 7 0066-4804/10/$12.00 doi:10.1128/aac.01601-09 Copyright 2010, American Society for Microbiology. All Rights Reserved. In Vitro
More informationIDENTIFICATION OF M. tuberculosis
Rev. 1 Pag. 1 di 7 Destinatari: Personale del Settore Diagnosi Microbiologica Avanzata e Settore Ricerca Micobatteri CONTENT 1. SCOPE 2. APPLICATION 3. DEFINITIONS AND ABBREVIATIONS 4. RESPONSIBILITIES
More informationFigure 44. Macroscopic view of a lung affected by TB. Caseous necrosis is extensive, and significant bronchogenic dissemination is also observed.
Figure 44. Macroscopic view of a lung affected by TB. Caseous necrosis is extensive, and significant bronchogenic dissemination is also observed. 114 Figure 45. Macroscopic view of a lung affected by miliary
More informationMAJOR ARTICLE. Effect of Drug Resistance on DOTS CID 2004:39 (1 November) 1321
MAJOR ARTICLE The Effect of Initial Drug Resistance on Treatment Response and Acquired Drug Resistance during Standardized Short-Course Chemotherapy for Tuberculosis Kwonjune J. Seung, 1 Irina E. Gelmanova,
More informationAspirin antagonism in isonizaid treatment of tuberculosis in mice ACCEPTED. Department of Molecular Microbiology & Immunology, Bloomberg School of
AAC Accepts, published online ahead of print on 4 December 2006 Antimicrob. Agents Chemother. doi:10.1128/aac.01145-06 Copyright 2006, American Society for Microbiology and/or the Listed Authors/Institutions.
More informationDiagnosis of TB: Laboratory Ken Jost Tuesday April 1, 2014
TB Nurse Case Management San Antonio, Texas April 1 3, 2014 Diagnosis of TB: Laboratory Ken Jost Tuesday April 1, 2014 Ken Jost, BA has the following disclosures to make: No conflict of interests No relevant
More informationA. De Logu, P. Uda, M.L. Pellerano, M.C. Pusceddu, B. Saddi, M.L. Schivo
Eur J Clin Microbiol Infect Dis (2001) 20 :33 39 Q Springer-Verlag 2001 Article Comparison of Two Rapid Colorimetric Methods for Determining Resistance of Mycobacterium tuberculosis to Rifampin, Isoniazid,
More informationTB/HIV 2 sides of the same coin. Dr. Shamma Shetye, MD Microbiology Metropolis Healthcare, Mumbai
TB/HIV 2 sides of the same coin Dr. Shamma Shetye, MD Microbiology Metropolis Healthcare, Mumbai Global- Tb new cases Diagnosis-Microscopy ZN,Flourescent microscopy(fm) Rapid, inexpensive test Specificity>95%
More informationSpread of Drug-Resistant Mycobacterium tuberculosis Strains of the Beijing Genotype in the Archangel Oblast, Russia
JOURNAL OF CLINICAL MICROBIOLOGY, June 2002, p. 1930 1937 Vol. 40, No. 6 0095-1137/02/$04.00 0 DOI: 10.1128/JCM.40.6.1930 1937.2002 Copyright 2002, American Society for Microbiology. All Rights Reserved.
More informationThe ABC s of AFB s Laboratory Testing for Tuberculosis. Gary Budnick Connecticut Department of Public Health Mycobacteriology Laboratory
The ABC s of AFB s Laboratory Testing for Tuberculosis Gary Budnick Connecticut Department of Public Health Mycobacteriology Laboratory Laboratory TAT Goals Case Study Specimen Collection Testing Contact
More informationJCM Accepts, published online ahead of print on 13 August 2008 J. Clin. Microbiol. doi: /jcm
JCM Accepts, published online ahead of print on 13 August 08 J. Clin. Microbiol. doi:.1128/jcm.083-07 Copyright 08, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights
More informationMolecular Methods in the Diagnosis of Drug Resistant Tuberculosis. Dr Sahajal Dhooria
Molecular Methods in the Diagnosis of Drug Resistant Tuberculosis Dr Sahajal Dhooria What is drug resistant TB? Definitions MDR TB defined as resistance to isoniazid and rifampicin, with or without resistance
More informationHow best to structure a laboratory network with new technologies
How best to structure a laboratory network with new technologies Cristina Gutierrez, MD, PhD Uniting to scale up TB care in Central Asia 14 and 15 April 2011 Tashkent, Uzbekistan New laboratory diagnostics
More informationPrimary anti-tuberculous drugs resistance of pulmonary tuberculosis in Southwestern Saudi Arabia
Journal of Infection and Public Health (2012) 5, 281 285 Primary anti-tuberculous drugs resistance of pulmonary tuberculosis in Southwestern Saudi Arabia Ahmed Morad Asaad, Jobran Miree Alqahtani Najran
More informationReceived 28 April 2005/Returned for modification 8 July 2005/Accepted 31 October 2005
JOURNAL OF CLINICAL MICROBIOLOGY, Mar. 2006, p. 811 818 Vol. 44, No. 3 0095-1137/06/$08.00 0 doi:10.1128/jcm.44.3.811 818.2006 Copyright 2006, American Society for Microbiology. All Rights Reserved. Evaluation
More informationORIGINAL ARTICLE. Department of Microbiology, Military Medical Academy, Belgrade, Yugoslavia. Clin Microbiol Infect 2002; 8:
ORIGINAL ARTICLE Evaluation of the MB/BacT System for recovery of mycobacteria from clinical specimens in comparison to Lowenstein Jensen medium V. Mirovic and Z. Lepsanovic Department of Microbiology,
More informationDST for detection of DR TB - roll out of Xpert in South Africa and overview of other technologies: what are the gaps?
DST for detection of DR TB - roll out of Xpert in South Africa and overview of other technologies: what are the gaps? Mark Nicol Division of Medical Microbiology and Institute for Infectious Diseases and
More informationInternational Journal of Pharma and Bio Sciences
Research Article Microbiology International Journal of Pharma and Bio Sciences ISSN 0975-6299 ANTI-TUBERCULOSIS DRUG RESISTANCE IN PREVIOUSLY UNTREATED PULMONARY TUBERCULOSIS PATIENTS IN PUNE, INDIA MICHAEL
More informationACCEPTED. Comparison of disk diffusion and agar dilution methods for erythromycin and
AAC Accepts, published online ahead of print on January 00 Antimicrob. Agents Chemother. doi:./aac.000-0 Copyright 00, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights
More information* WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Care and
ERJ Express. Published on August 9, 2007 as doi: 10.1183/09031936.00077307 RAPID PUBLICATION Clinical and operational value of the XDR-TB definition Giovanni Battista Migliori *, Giorgio Besozzi, Enrico
More informationDNA sequencing for the confirmation of rifampin resistance detected by Cepheid Xpert
JCM Accepted Manuscript Posted Online 4 March 2015 J. Clin. Microbiol. doi:10.1128/jcm.03433-14 Copyright 2015, American Society for Microbiology. All Rights Reserved. 1 2 DNA sequencing for the confirmation
More informationXpert MTB/RIF Training. Indira Soundiram 2012
Xpert MTB/RIF Training Indira Soundiram 2012 A Better Way to Platform Design GeneXpert Infinity-48 GeneXpert Module GX-I GX-II GX-IV GX-XVI 2 Defining Molecular Diagnostics Any Test Any Time Any Sample
More informationEthambutol MICs and MBCs for Mycobacterium avium Complex
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Dec. 1986, p. 927-932 66-484/86/12927-6$2./ Copyright 1986, American Society for Microbiology Vol. 3, No. 6 Ethambutol MICs and MBCs for Mycobacterium avium Complex
More informationHarmonizing the Use of Molecular & Culture-based DST of Mycobacterium tuberculosis
Harmonizing the Use of Molecular & Culture-based DST of Mycobacterium tuberculosis Grace Lin, MS. Research Scientist grace.lin@cdph.ca.gov APHL 8 th TB Lab Conference San Diego 8-19-13 Harmonizing? There
More informationClinical Evaluation of the Microscopic-Observation Drug-Susceptibility Assay for Detection of Tuberculosis
MAJOR ARTICLE Clinical Evaluation of the Microscopic-Observation Drug-Susceptibility Assay for Detection of Tuberculosis Mayra Arias, 1,a Fernanda C. Q. Mello, 4,a Ada Pavón, 5 Anna Grazia Marsico, 4 Carlos
More informationDrug-Susceptible Mycobacterium tuberculosis Beijing Genotype Does Not Develop Mutation-Conferred Resistance to Rifampin at an Elevated Rate
JOURNAL OF CLINICAL MICROBIOLOGY, Apr. 2003, p. 1520 1524 Vol. 41, No. 4 0095-1137/03/$08.00 0 DOI: 10.1128/JCM.41.4.1520 1524.2003 Copyright 2003, American Society for Microbiology. All Rights Reserved.
More informationMulti-drug Resistant Tuberculosis in Rajshahi District
TAJ December 2005; Volume 18 Number 2 ISSN 1019-8555 The Journal of Teachers Association RMC, Rajshahi Original Article Multi-drug Resistant Tuberculosis in Rajshahi District M Wasim Hussain, 1 M Azizul
More informationReceived 21 April 1997/Returned for modification 30 June 1997/Accepted 28 August 1997
JOURNAL OF CLINICAL MICROBIOLOGY, Dec. 1997, p. 3258 3263 Vol. 35, No. 12 0095-1137/97/$04.00 0 Copyright 1997, American Society for Microbiology Comparison of Agar Dilution, Broth Microdilution, E-Test,
More informationTuberculosis Diagnosis and Multidrug Resistance Testing by Direct Sputum Culture in Selective Broth without Decontamination or Centrifugation
JOURNAL OF CLINICAL MICROBIOLOGY, July 2008, p. 2339 2344 Vol. 46, No. 7 0095-1137/08/$08.00 0 doi:10.1128/jcm.02476-07 Copyright 2008, American Society for Microbiology. All Rights Reserved. Tuberculosis
More information